Unenhanced breast MRI (STIR, T2-weighted TSE, DWIBS): An accurate and alternative strategy for detecting and differentiating breast lesions

Magnetic Resonance Imaging

Volumn 33, Issue 8, 2015, Pages 951-955

  Telegrafo, Michele ^a   Rella, Leonarda ^a   Stabile Ianora, Amato Antonio ^a   Angelelli, Giuseppe ^a   Moschetta, Marco ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Breast; DWIBS; MRI; STIR; T2 TSE; Unenhanced imaging

Indexed keywords

ADULT; AGED; ARTICLE; BREAST ADENOMA; BREAST CARCINOMA; BREAST CYST; BREAST FIBROSIS; BREAST HYPERPLASIA; BREAST LESION; COLLOID CARCINOMA; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTRADUCTAL CARCINOMA; LIPOMATOSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ALGORITHM; AUTOMATED PATTERN RECOGNITION; BREAST TUMOR; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY;

NUCLEOPOLYHEDROVIRUS;

ADULT; AGED; ALGORITHMS; BREAST NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MIDDLE AGED; PATTERN RECOGNITION, AUTOMATED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84939573859     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2015.06.002     Document Type: Article

References (29)

1. Heywang-Kobrunner S.H. Contrast-enhanced magnetic resonance imaging of the breast. Invest Radiol 1994, 29:94-104.
2. Orel S.G., Schnall M.D., Livolsi V.A., Troupin R.H. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994, 190:485-493.
3. Huang W., Fisher P.R., Dulaimy K., Tudorica L.A., O'Hea B., Button T.M. Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 2004, 232:585-591.
4. Kuhl C.K. MRI of breast tumors. Eur Radiol 2000, 10:46-58.
5. Baum F., Fischer U., Vosshenrich R., Grabbe E. Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 2002, 12:1087-1092.
6. Moschetta M., Telegrafo M., Rella L., Stabile Ianora A.A., Angelelli G. Let's go out of the breast: prevalence of extra-mammary findings and their characterization on breast MRI. Eur J Radiol 2014, 83(6):930-934.
7. Hoffmann U., Brix G., Knopp M.V., Hess T., Lorenz W.J. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995, 33:506-514.
8. Kuhl C.K., Mielcareck P., Klaschik S., Leutner C., Wardelmann E., Gieseke J., et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 1999, 211:101-110.
9. Degani H., Gusis V., Weinstein D., Fields S., Strano S. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nat Med 1997, 3:780-782.
10. Orel S.G. High-resolution MR, imaging for the detection, diagnosis, and staging of breast cancer. RadioGraphics 1998, 18:903-912.
11. Vestito A., Mangieri F.F., Gatta G., Moschetta M., Turi B., Ancona A. Breast carcinoma in elderly women. Our experience. G Chir 2011, 32:411-416.
12. Agarwal R., Brunelli S.M., Williams K., Mitchell M.D., Feldman H.I., Umscheid C.A. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis. Nephrol Dial Transplant 2009, 24:856-863.
13. Bellin M.F., Van Der Molen A.J. Extracellular gadolinium-based contrast media: an overview. Eur J Radiol 2008, 66:160-167.
14. Belli P., Costantini M., Bufi E., Magistrelli A., La Torre G., Bonomo L. Diffusion weighted imaging in breast lesione valuation. Radiol Med 2010, 115:51-69.
15. Kul S., Cansu A., Alhan E., Dinc H., Gunes G., Reis A. Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. AJR Am J Roentgenol 2011, 196:210-217.
16. Spick C., Pinker-Domenig K., Rudas M., Helbich T.H., Baltzer P.A. MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies. Eur Radiol 2014, 24(6):1204-1210.
17. Moschetta M., Telegrafo M., Rella L., Capolongo A., Stabile Ianora A.A., Angelelli G. MR evaluation of breast lesions obtained by diffusion-weighted imaging with background body signal suppression (DWIBS) and correlations with histological findings. Magn Reson Imaging 2014, 32(6):605-609.
18. Stadlbauer A., Bernt R., Gruber S., Bogner W., Pinker K., van der Riet W., et al. Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions. Eur Radiol 2009, 19:2349-2356.
19. Baltzer P.A., Benndorf M., Dietzel M., Gajda M., Camara O., Kaiser W.A. Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions. Eur Radiol 2010, 20(5):1101-1110.
20. Kuroki-Suzuki S., Kuroki Y., Nasu K., Nawano S., Moriyama N., Okazaki M. Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging. Magn Reson Med Sci 2007, 6(1):21-27.
21. Pediconi F., Catalano C., Occhiato R., Venditti F., Fraioli F., Napoli A., et al. Breast lesion detection and characterization at contrast-enhanced MR mammography: Gadobenate Dimeglumine versus Gadopentat Dimeglumine. Radiology 2005, 237:45-56.
22. Haddadin I.S., McIntosh A., Meisamy S., Corum C., Styczynski Snyder A.L., Powell N.J., et al. Metabolite quantification and high-field MRS in breast cancer. NMR Biomed 2009, 22:65-76.
23. Mountford C., Ramadan S., Stanwell P., Malycha P. Proton MRS of the breast in the clinical setting. NMR Biomed 2009, 22:54-64.
24. Santamaría G., Velasco M., Bargalló X., Caparrós X., Farrús B., Luis Fernández P. Radiologic and pathologic findings in breast tumors with high signal intensity on T2-weighted MR images. Radiographics 2010, 30(2):533-548.
25. Begley J.K., Redpath T.W., Bolan P.J., Gilbert F.J. In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literature. Breast Cancer Res 2012, 14:207.
26. Thomassin-Naggara I., De Bazelaire C., Chopier J., Bazot M., Marsault C., Trop I. Diffusion-weighted MR imaging of the breast: advantages and pitfalls. Eur J Radiol 2013, 82(3):435-443.
27. Chiu F.Y., Jao J.C., Chen C.Y., Liu G.C., Jaw T.S., Chiou Y.Y., et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. J Comput Assist Tomogr 2005, 29:176-180.
28. Benndorf M., Schelhorn J., Dietzel M., Kaiser W.A., Baltzer P.A. Diffusion weighted imaging of liver lesions suspect for metastases: apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration. Eur J Radiol 2012, 81:849-853.
29. Moschetta M., Telegrafo M., Rella L., Stabile Ianora A.A., Angelelli G. Effect of gadolinium injection on diffusion-weighted imaging with background body signal suppression (DWIBS) imaging of breast lesions. Magn Reson Imaging 2014, 32(10):1242-1246.